Jennifer Hu
About Jennifer Hu
Jennifer Hu is a Sr. Principal Scientist at Bristol Myers Squibb in Seattle, specializing in Cell Therapy Product & Analytical Development.
Current Title and Role
Jennifer Hu is a Sr. Principal Scientist at Bristol Myers Squibb, where she focuses on cell therapy product and analytical development. She has been with the company since July 2021 and is based in the Greater Seattle Area. Her role involves significant responsibilities in the realm of scientific and research-based endeavors within the organization.
Educational Background
Jennifer Hu obtained her Doctor of Philosophy (Ph.D.) from the Massachusetts Institute of Technology, completing her studies from 2014 to 2019. Prior to that, she achieved her Bachelor of Science (B.S.) from the University of California, Berkeley, where she studied from 2005 to 2009. This academic background laid a strong foundation for her career in scientific research.
Specialization in Cell Therapy
Jennifer Hu specialized in cell therapy product and analytical development. Her expertise in this field involves the advancement and assessment of cell-based therapeutic products, ensuring their efficacy and safety. This specialization is critical in the development of new treatments and therapies aimed at addressing various medical conditions.
Professional Experience
With a strong background in both academic and industry settings, Jennifer Hu combines her extensive research knowledge with practical industry experience. Her academic studies at prestigious institutions and her current role at Bristol Myers Squibb highlight her capability and contributions to the field of cell therapy and scientific research.